Pharmacokinetic Assessment of PF-00299804 in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Following Administration Through a Gastrojejunostomy Feeding Tube
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2015
At a glance
- Drugs Dacomitinib (Primary)
- Indications Head and neck cancer
- Focus Pharmacokinetics
- 09 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 28 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 28 May 2013 Planned end date changed from 1 Jun 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.